Cargando…
The atypical cyclin CNTD2 promotes colon cancer cell proliferation and migration
Colorectal cancer (CRC) is one of the most common cancers worldwide, with 8–10% of these tumours presenting a BRAF (V600E) mutation. Cyclins are known oncogenes deregulated in many cancers, but the role of the new subfamily of atypical cyclins remains elusive. Here we have performed a systematic ana...
Autores principales: | Sánchez-Botet, Abril, Gasa, Laura, Quandt, Eva, Hernández-Ortega, Sara, Jiménez, Javier, Mezquita, Pau, Carrasco-García, Miquel Àngel, Kron, Stephen J., Vidal, August, Villanueva, Alberto, Ribeiro, Mariana P. C., Clotet, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081371/ https://www.ncbi.nlm.nih.gov/pubmed/30087414 http://dx.doi.org/10.1038/s41598-018-30307-x |
Ejemplares similares
-
A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancer
por: Gasa, L., et al.
Publicado: (2017) -
Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway
por: Sánchez-Botet, Abril, et al.
Publicado: (2021) -
CDK6 is activated by the atypical cyclin I to promote E2F‐mediated gene expression and cancer cell proliferation
por: Quandt, Eva, et al.
Publicado: (2023) -
Atypical cyclins: the extended family portrait
por: Quandt, Eva, et al.
Publicado: (2019) -
Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex
por: Hernández-Ortega, Sara, et al.
Publicado: (2019)